Morgan Stanley Cuts Edwards Lifesciences (NYSE:EW) Price Target to $80.00

Edwards Lifesciences (NYSE:EW – Free Report) had its target price cut by Morgan Stanley from $102.00 to $80.00 in a research report report published on Monday morning, Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Other research analysts also recently issued research reports about the stock. Citigroup dropped their […]

Leave a Reply

Your email address will not be published.

Previous post CNH Industrial (NYSE:CNHI) Given New $17.57 Price Target at The Goldman Sachs Group
Next post Brokerages Set Hikma Pharmaceuticals PLC (LON:HIK) PT at GBX 1,972.50